SCHEMBL5328979

SCHEMBL5328979

N#Cc1cccc(-c2csc3nc(C45CC6CC(CC(C6)C4)C5)cn23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.41
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A3 P47895 1/20 0.35
KDM1A O60341 1/20 0.35
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
PKM P14618 1/20 0.34
STS P08842 1/20 0.34
UCHL1 P09936 1/20 0.34
USP30 Q70CQ3 1/20 0.34
PDE4D Q08499 2/20 0.34
EGLN2 Q96KS0 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
HSD11B1 P28845 1/20 0.33
BACE1 P56817 2/20 0.33
IDO1 P14902 2/20 0.33
F11 P03951 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5327767 0.99 FAAH (0.40) FAAHKDM4EALDH1A1MEN1KMT2A
SCHEMBL5333174 0.89 ALDH1A1 (0.37) KDM4EALDH1A1MEN1KMT2ALMNA
Hydrochloric Acid SCHEMBL5324966 0.88 ALDH1A1 (0.36) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL8228997 0.87 FAAH (0.34) FAAHALDH1A3UCHL1USP30PDE4D
SCHEMBL14340786 0.85 ALDH1A1 (0.46) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL5331736 0.85 SMN1; SMN2 (0.39) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL5323440 0.85 CA12 (0.38) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL5328131 0.85 PTGS2 (0.38) FAAHKDM4EALDH1A1MEN1KMT2A
SCHEMBL5330842 0.85 ALDH1A1 (0.38) KDM4EALDH1A1MEN1KMT2ALMNA
Hydrochloric Acid SCHEMBL5331189 0.84 ALDH1A1 (0.37) KDM4EALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US claimed
WO-2007148113-A1 METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 WO claimed
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US disclosed
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US disclosed
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US disclosed
WO-2007148113-A1 METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299113-A1 Metabotropic glutamate receptor modulators GRM1, GRM2, GRM3 FAAH 441/4885KDM4E 1726/4885ALDH1A1 2824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.